Signaling pathways regulating CD44-dependent cytolysis in natural killer cells

Blood

Volumn 90, Issue 2, 1997, Pages 716-725

  Sconocchia, Giuseppe ^a   Titus, Julie A ^a   Segal, David M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; INTERLEUKIN 2; PERFORIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; WORTMANNIN;

ACTIN POLYMERIZATION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CYTOLYSIS; CYTOSKELETON; CYTOTOXICITY; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0030756220     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.716.716_716_725     Document Type: Article

References (55)

1. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
2. Lanier LL, Yu G, Phillips JH: Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342:803, 1989
3. Manciulea M, Rabinowich H, Sulica A, Lin WC, Whiteside TL, DeLeo A, Herberman RB, Corey SJ: Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells. Cell Immunol 167:63, 1996
4. Ravetch JV, Kinet JP: Fc receptors. Annu Rev Immunol 9:457, 1991
5. Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N. Augugliaro R, Bottino C, Ciccone E, Moretta L: CD69-mediated pathway of lymphocyte activation: Anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J Exp Med 174:1393, 1991
6. Testi R, D'Ambrosio D, De Maria R, Santoni A: The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15:479, 1994
7. Sconocchia G, Titus JA, Segal DM: CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol 153:5473, 1994
8. Yang H, Binns RM: CD44 is involved in porcine natural cytotoxicity. Cell Immunol 149:227, 1993
9. Tan PH, Liu YF, Santos EB, Sandmaier BM: Mechanisms of enhancement of natural killer activity by an antibody to CD44: Increase conjugate formation and release of tumor necrosis factor α. Cell Immunol 164:255, 1995
10. Galandrini R, De Maria R, Piccoli M, Frati L, Santoni A: CD44 triggering enhances human NK cell cytotoxic functions. J Immunol 153:4399, 1994
11. MEL-14. Proc Natl Acad Sci USA 88:7877, 1991
12. Galandrini R, Albi N, Tripodi G, Zarcone D, Terenzi A, Moretta A, Grossi CE, Velardi A: Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 150:4225, 1993
13. Pericle F, Sconocchia G, Titus JA, Segal DM: CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol 157:4657, 1996
14. Conrad P, Rothman BL, Kelley KA, Blue M-L: Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J Immunol 149:1833, 1992
15. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271, 1993
16. Haynes BF, Telen MJ, Hale LP, Denning SM: CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423, 1989
17. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
18. Zhou DF, Ding JF, Picker LJ, Bargatze RF, Butcher EC, Goeddel DV: Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J Immunol 143:3390, 1989
19. Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC: A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56:1063, 1989
20. Tolg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225, 1993
21. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160, 1992
22. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235, 1993
23. Herrlich P, Zöller M, Pals ST, Ponta H: CD44 splice variants: Metastases meet lymphocytes. Immunol Today 14:395, 1993
24. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
25. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682, 1992
26. Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C, Silorski ES: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111:2765, 1990
27. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391, 1994
28. Bourguignon LYW, Lokeshwar VB, Chen X, Kerrick WGL: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 151:6634, 1993
29. Bourguignon LYW, Lokeshwar VB, He J, Chen X, Bourguignon GJ: A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol 12:4464, 1992
30. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakanes M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771, 1991
31. Phillips JH, Warner NL, Lanier LL: Correlation of biophysical properties and cell surface antigenic profile of Percoll gradient-separated human natural killer cells. Nat Immun Cell Growth Regul 3:73, 1983
32. Wunderlich JR, Shearer GM: Induction and measurement of cytotoxic T lymphocyte activity, Unit 3.11, in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology, Vol 1. New York, NY, Wiley, 1991, p 3.11.1
33. Lisanti MP, Sargiacomo M: Biotinylation and analysis of membrane-bound and soluble proteins, in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology. New York, NY, Wiley, 1995, p 8.16.1
34. Perez P, Bluestone JA, Stephany DA, Segal DM: Quantitative measurements of the specificity and kinetics of conjugate formation between cloned cytotoxic T lymphocytes and splenic target cells by dual parameter flow cytometry. J Immunol 134:478, 1985
35. Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K: Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 156:3678, 1996
36. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F: Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135:397, 1986
37. O'Shea JJ, McVicar DW, Kuhns DB, Ortaldo JR: A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. J Immunol 148:2497, 1992
38. Bonnema JD, Karnitz LM, Schoon RA, Abraham RT, Leibson PJ: Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med 180:1427, 1994
39. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y: Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268:25846, 1993
40. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H: Integrin-dependent translocation of phosphoinositide 3-kinase in the cytoskeleton of thrombin-activated platelets involves specific interactions of p85alpha with actin filaments and focal adhesion kinase. J Cell Biol 129:831, 1995
41. Bokoch GM, Vlahos CJ, Wang Y, Knaus UG, Traynor-Kaplan AE: Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem J 315:775, 1996
42. Henkart PA: Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1:343, 1994
43. Matsumura Y, Tarin D: Significance of CD44 gene product for cancer diagnosis and disease evaluation. Lancet 340:1053, 1992
44. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW: Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. J Exp Med 175:257, 1992
45. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW: Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419, 1995
46. Lesley J, English N, Perschl A, Gregoroff J, Hyman R: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182:431, 1995
47. Uff CR, Neame SJ, Isacke CM: Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur J Immunol 25:1883, 1995
48. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I: Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199, 1996
49. Puré E, Camp RL, Peritt D, Panettieri RA Jr, Lazaar AL, Nayak S: Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181:55, 1995
50. Varticovski L, Harrison-Findik D, Keeler ML, Susa M: Role of PI 3-kinase in mitogenesis. Biochim Biophys Acta 1226:1, 1994
51. Fry MJ, Waterfield MD: Structure and function of phosphatidylinositol 3-kinase: A potential second messenger system involved in growth control. Phil Trans R Soc Lond B Biol Sci 340:337, 1993
52. Salcedo TW, Kurosaki T, Kanakaraj P, Ravetch JV, Perussia B: Physical and functional association of p561ck with Fc gamma RIIIA (CD16) in natural killer cells. J Exp Med 177:1475, 1993
53. Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST: Signaling through CD44 is mediated by tyrosine kinases. Association with p561ck in T lymphocytes. J Biol Chem 271:2863, 1996
54. Martz E: Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes: Resolution and characterization of discrete steps in the cellular interaction. Contemp Top Immunobiol 7:301, 1977
55. Lub M, van Kooyk Y, Figdor CG: Ins and outs of LFA-1. Immunol Today 16:479, 1995